• Mashup Score: 6

    Dietary choices are crucial for managing type 2 diabetes. Experts including Roy Taylor, MD, shared their perspectives on nutrition programs that have helped patients reduce or manage type 2 diabetes while also living healthier lives. These programs incorporate low-calorie diets, low-carb diets, and glycemic excursion minimization.

    Tweet Tweets with this article
    • "Efficacy, Engagement, and Sustainability of Dietary Management Options in Type 2 Diabetes: Time for a Reappraisal? — Roy Taylor, MD; Nia Schwann Mitchell, MD, MPH; and Daniel Cox, PhD, presented Friday at #ADA2023. Read a recap in ADA Meeting News: https://t.co/ej2yOUNcqX" https://t.co/fZSLc2Mobi

  • Mashup Score: 7

    Sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists are making an impact in treating patients with type 2 diabetes who may be at high risk for atherosclerotic cardiovascular disease and heart failure. Darren K. McGuire, MD, MHSc, will review both classes of drugs as part of an expert panel.

    Tweet Tweets with this article
    • Proud to present tomorrow the latest evidence at #ADA2023 about SGLT2i and heart failure. Best panel ever with my friends Darren McGuire (discussing SGLT2i/GLP1RA) and @PamTaubMD (discussing GLP-1RA in CVD), moderated by @gandaom @DLBHATTMD @GoggleDocs https://t.co/kOM7zQKQNC https://t.co/rQ3oAUs24E

  • Mashup Score: 3

    Various self-assessment tools exist to help patients with diabetes monitor their daily activities and provide their care teams with insights into glucose levels. Methods for tracking behavioral markers include sleep monitoring and actigraphy devices to track physical activity. Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN, discussed ecological momentary assessments.

    Tweet Tweets with this article
    • Behavioral Markers of Diabetes Self-Management: State of the Science and Measurement Controversies — Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN; Carla K. Miller, PhD, RD; @sarahjaser2 and @jmjakicic presented at #ADA2023. Recap in ADA Meeting News: https://t.co/gYhzKkcE3J https://t.co/yPeuGOSrDi

  • Mashup Score: 0

    During a special Saturday morning lecture, American Diabetes Association® President of Health Care & Education Janet Brown-Friday, RN, MSN, MPH, urged the medical community to be inclusive of sex and gender, race and ethnicity among staff and participants when recruiting for trials. This also includes helping make access to trials more available to participants.

    Tweet Tweets with this article
    • Diversity in Clinical Trials: A Complicated Issue, Not a Simple Solution — ADA President, Health Care & Education Janet Brown-Friday, RN, MSN, MPH, delivered this address Saturday at #ADA2023. Read a recap in ADA Meeting News: https://t.co/DWugJkrHWx https://t.co/n2v5LzNPC2